Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

The Lancet Oncology

Volumn 17, Issue 6, 2016, Pages 757-767

  Leiter, Ulrike ^a   Stadler, Rudolf ^b   Mauch, Cornelia ^c   Hohenberger, Werner ^d   Brockmeyer, Norbert ^e   Berking, Carola ^f   Sunderkötter, Cord ^g   Kaatz, Martin ^h   Schulte, Klaus Werner ⁱ   Lehmann, Percy ^j   Vogt, Thomas ^k   Ulrich, Jens ^l,m   Herbst, Rudolf ⁿ   Gehring, Wolfgang ^o   Simon, Jan Christoph ^p   Keim, Ulrike ^a   Martus, Peter ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KLINIKUM MINDEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j Medical Hospital   (Germany)

^k SAARLAND UNIVERSITY   (Germany)

^l OTTO VON GUERICKE UNIVERSITY   (Germany)

^m Department of Dermatology   (Germany)

ⁿ Department of Dermatology   (Germany)

^o Medical Hospital   (Germany)

^p UNIVERSITY OF LEIPZIG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS FREE SURVIVAL; EVIDENCE BASED MEDICINE; FEMALE; FISTULA; HUMAN; INFECTION; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SEROMA; WOUND HEALING IMPAIRMENT; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PROGNOSIS; SENTINEL LYMPH NODE; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM MICROMETASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 84965027970     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)00141-8     Document Type: Article

References (31)

1. 1 Reintgen, DS, Cox, EB, McCarty, KS Jr, Vollmer, RT, Seigler, HF, Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 198 (1983), 379–385.
2. 2 Balch, CM, The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 6 (1988), 163–172.
3. 3 McCarthy, WH, Shaw, HM, Milton, GW, Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 161 (1985), 575–580.
4. 4 Balch, CM, Soong, SJ, Bartolucci, AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224 (1996), 255–263.
5. 5 Sim, FH, Taylor, WF, Pritchard, DJ, Soule, EH, Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61 (1986), 697–705.
6. 6 Veronesi, U, Adamus, J, Bandiera, DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 297 (1977), 627–630.
7. 7 Morton, DL, Thompson, JF, Essner, R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230 (1999), 453–463.
8. 8 Morton, DL, Cochran, AJ, The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 151 (2004), 308–319.
9. 9 Morton, DL, Thompson, JF, Cochran, AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006), 1307–1317.
10. 10 Morton, DL, Thompson, JF, Cochran, AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370 (2014), 599–609.
11. 11 van Akkooi, AC, de Wilt, JH, Verhoef, C, Eggermont, AM, The Rotterdam criteria for sentinel node tumor load: the simplest prognostic factor?. J ClinOncol, 26, 2008, 6011.
12. 12 Balch, CM, Buzaid, AC, Soong, SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001), 3635–3648.
13. 13 Giuliano, AE, Hunt, KK, Ballman, KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305 (2011), 569–575.
14. 14 Leong, SP, Role of selective sentinel lymph node dissection in head and neck melanoma. J Surg Oncol 104 (2011), 361–368.
15. 15 Galimberti, V, Cole, BF, Zurrida, S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14 (2013), 297–305.
16. 16 van der Ploeg, AP, van Akkooi, AC, Rutkowski, P, et al. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection. Br J Surg 99 (2012), 1396–1405.
17. 17 Satzger, I, Meier, A, Zapf, A, Niebuhr, M, Kapp, A, Gutzmer, R, Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?. Melanoma Res 24 (2014), 454–461.
18. 18 van der Ploeg, AP, van Akkooi, AC, Verhoef, C, Eggermont, AM, Completion lymph node dissection after a positive sentinel node: no longer a must?. Curr Opin Oncol 25 (2013), 152–159.
19. 19 Veronesi, U, Regional lymph node dissection in melanoma of the limbs. Stage I. A cooperative international trial (WHO Collaborating Centers for diagnosis and treatment of melanoma). Recent Results Cancer Res, 62, 1977, 8.
20. 20 Fife, K, Thompson, JF, Lymph-node metastases in patients with melanoma: what is the optimum management?. Lancet Oncol 2 (2001), 614–621.
21. 21 Bamboat, ZM, Konstantinidis, IT, Kuk, D, Ariyan, CE, Brady, MS, Coit, DG, Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 21 (2014), 3117–3123.
22. 22 Veronesi, U, Viale, G, Paganelli, G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251 (2010), 595–600.
23. 23 Feldmann, R, Fink, AM, Jurecka, W, Rappersberger, K, Steiner, A, Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study. Eur J Surg Oncol 40 (2014), 73–76.
24. 24 Cascinelli, N, Morabito, A, Santinami, M, MacKie, RM, Belli, F, Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351 (1998), 793–796.
25. 25 de Vries, M, Vonkeman, WG, van Ginkel, RJ, Hoekstra, HJ, Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 32 (2006), 785–789.
26. 26 Guggenheim, MM, Hug, U, Jung, FJ, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 247 (2008), 687–693.
27. 27 van Akkooi, AC, Bouwhuis, MG, van Geel, AN, et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 33 (2007), 102–128.
28. 28 Slagelse, C, Petersen, KL, Dahl, JB, et al. Persistent postoperative pain and sensory changes following lymph node excision in melanoma patients: a topical review. Melanoma Res 24 (2014), 93–98.
29. 29 Wrightson, WR, Wong, SL, Edwards, MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 10 (2003), 676–680.
30. 30 de Vries, M, Hoekstra, HJ, Hoekstra-Weebers, JE, Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol 16 (2009), 2840–2847.
31. 31 Pasquali, S, Mocellin, S, Mozzillo, N, et al. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol 32 (2014), 935–941.